Pharmafile Logo
Pharmafocus logo
Advanced Search

Les Rose

Showing 11 posts of 26 posts found.

Lab image

Does drug development deliver on its promises?

October 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, R&D

I am always guided by the motto of the Royal Society, ‘Nullius in Verba’. This means, with typical Latin brevity: …

Feature

Analysis paralysis – how to get the true measure of clinical trials

July 20, 2011
Research and Development Les Rose, clinical trials

The great physicist Lord Kelvin famously said: “When you can measure what you are speaking about, and express it in …

Feature

Evil big pharma: myth or material?

April 6, 2011
Research and Development, Sales and Marketing Les Rose, industry reputation

In the US the False Claims Act regulates those who attempt to defraud the government. In the last 20 years, …

Feature

Health outcomes – does anything else matter?

October 27, 2010
Research and Development Les Rose, evidence-based medicine, healthcare outcomes, randomised controlled trials

So the mould of British politics has been broken, and we now have a government with probably a broader range …

Feature

Not so new technologies

July 28, 2010
Research and Development EDC, Les Rose, digital research

Let me take you back to a time that is now only dimly remembered. I don’t mean a time when …

Feature

Power to the project manager

July 14, 2010
Research and Development Les Rose, project management

It’s an interesting exercise to peruse the job ads these days, even if you are not actually looking for a …

Feature
Money trap

Drug development: where’s the added investment value?

February 18, 2010
Research and Development CRO, Les Rose, R&D, biotech, funding

Venture capital is a curious business. The global financial crisis which we are slowly emerging from has exposed some rather …

Feature

Building value – is the pipeline all that matters?

December 1, 2009
Research and Development Les Rose, biotech, venture capital

Venture capital is a curious business and the global financial crisis in which we find ourselves has exposed some rather …

Feature

Whatever happened to yesterday’s ‘magic bullets’?

November 3, 2009
Research and Development Les Rose, biotech

How many of you remember when monoclonal antibodies were called `magic bullets’? Enough time has passed since the term first …

Feature

Is the law good for your health?

June 30, 2009
Research and Development Les Rose, law, science

 A lawyer once told me that the law has nothing to do with morals. This wasn’t really a surprise, but …

Feature

Efficacy or effectiveness?

December 9, 2008
Research and Development Les Rose, clinical trials, evidence

The question of ‘generalisability’ – or the extent clinical trials can be applied to the real world, has been an …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025